PDF
XLS
DOC
DOC
Johnson & Johnson Pricing Transparency Report
View report
Our R&D investments
Drug list prices
Rebates, discounts & fees
Affordable access
The 340B program
Valuing pharmaceuticals in the U.S.
What we believe
Citations
Read full report
Fast facts
2023 at a glance
$42.8 Billion: breaking it down
Rebates, discounts and fees
Watch: 2023 Transparency Report
PDABs and UPLs
The 340B program
Archive
Menu
Archive
View report
Our R&D investments
Drug list prices
Rebates, discounts & fees
Affordable access
The 340B program
Valuing pharmaceuticals in the U.S.
What we believe
Citations
Read full report
Fast facts
2023 at a glance
$42.8 Billion: breaking it down
Rebates, discounts and fees
Watch: 2023 Transparency Report
PDABs and UPLs
The 340B program
$42.8 billion: breaking it down